Log In
Register
Facebook icon
Instagram icon
Twitter X icon
LinkedIn icon
Business
Research
Treatments
News
Products
Multimedia
Site Map
2022
April
28
Aesthetic Society Announces New Leaders
FDA Accepts Revance BLA Resubmission for DaxibotulinumtoxinA
Complication Rate of Nonablative Devices for Skin Types IV-VI
Page 1 of 1